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Abstract 
Hypovitaminosis 0 may be associated with diabetes, hypertension and CHD. However, because studies examining the associations of 
all three chro nic conditions with circulating 25-hydroxyvitamin D (25(0H)D) and 1,25-dihydroxyvitamin D (1,25(0H)2D) are limited, 
we examined these associations in the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (n 2465) . Caucasian 
PLCO participants selected as controls in previous nested case-control studies of 25(0H) D and 1,25(0H)2D were included in this 
analysis. Diabetes, CHD and hypertension prevalence, risk factors for these conditions and intake of vitamin D and Ca were collected 
from a baseline questionnaire. Results indicated that serum levels of 25(0H)D were low (<50 nmol/1) in 29% and very low 
( < 37 nmol/1) in 11 % of subjects. The prevalence of d iabetes, hypertension and CHD was 7, 30 and 10%, respectively. After adjustment 
for confounding by sex, geographical location, educational level, smoking history, BMI, physical activity, total dietary energy and 
vitamin D and Ca intake, only diabetes was significantly associated with lower 25(0H) D a nd 1,25(0H)2D levels. Caucasians who 
had 25(0H) D 2:80nmol/1 were half as likely to have diabetes (OR 0·5 (95 % Cl 0·3, 0·9)) compared with those who had 25(0H)D 
<37 nmol/l. Those in the highest quartile of 1,25(0H)2D (2: 103 pmol/1) were less than half as likely to have diabetes (OR 0·3 
(95 % Cl 0·1, 0·7)) than those in the lowest quartile (< 72pmol/ l). In conclusion, the independent associations of 25(0H)D and 
1,25(0H)2D with d iabetes prevalence in a large populatio n are new findings, and thus warrant confirmation in larger, prospective 
studies. 
Key words: Diabetes: Vitamin D s tatus: 25-Hydro xyvitamin D: 1,25-Dihydroxyvitamin D 
Abbre viations: 1,25(0H)2D, 1,25-clihyclroxyvitamin D; 25(0H)D, 25-hyclroxyvitamin D; PA, physical activity. 
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Vitamin D is a ste ro id pro-hormone synthesised in the skin 
following lN exposure o r through supplemental or dieta ry 
intake . In addition to maintaining bone and muscle health, 
vitamin D has recently been postulated to protect against 
3immune dysfunction, cancer(!), cardiovascular conditionsc2' ), 
4hype Jte nsionc3• ) , metabolic syndrome and diabetes(;) 
The concentration of 25-hydroxyvitamin D (25(0H)D), 
the major circulating fo rm of vitamin D in the blood, rises 
and falls with the supply of vitamin D; on the othe r hand, 
the concenu-ation of ci rculating 1 ,25-d ihyd roxyvitamin D 
(1,25(0H)2D) (the biologically active form) is th ought to be 
kept under tight homeostatic contro l and is thus largely inde­
pendent of vitamin D supply, except in severe deficienc/n 
As early as the 1980s, animal studies identified the 
expression of the vitamin D recepto r in rat pancreatic 
cells and demonstrated that vitamin D deficie ncy inhibits 
the production of insulinc6•7) To our knowledge, no large 
epidemiological analysis study has investigated simul­
taneously diabetes, hypertension and CHD risk together with 
vitamin D blood levels. Thus, the aim of the present study 
was to investigate the association between diabetes, hyper­
tension and CHD and two serum bio-marke rs associated 
with vitamin D function, 25(0H)D and 1,25(0H)2D. 
Materials and methods 
In the present study, we analysed data from subjects selected 
as controls in five previous case- control studies of circulating 
vitamin D biomarkers (25(0H)D and 1,25(0H)2D) nested 
within the Prostate Lung Colon and Ovalian Trial (PLCO), 
which was a large, randomised, controlled multicentre trial in 
the USA with 155 000 men and women at sites in Birmingham, 
AL; Denver, CO; Detroit, MI; Honolulu, HI; Marshfield, WI; 
Minneapo lis, MN; Pittsburgh, PA; Salt Lake City, UT; St Louis, 
MO; and Washington, DC, which was designed to evaluate 
selected methods for the ea rly detection of these four cancers 
as well as non-Hodgkin's lymphoma, breast and pancreatic 
cancer. Enrolment began on 1 November 1993 and ended 
on 30 June 2001(8) Details of these studies of colo rectal 
adenoma, non-Hodgkin's lymphoma and prostate, breast 
and pancreatic cancer are described elsewhere (9) Briefly, we 
included 399 controls used for a study of colo rectal adenoma 
(matched to cases by sex and race), 286 contro ls used for a 
study of non-Hodgkin 's lymphoma, 713 controls used for a 
study of prostate cancer (matched to cases by age, time 
since screening and year of follow-up), 932 controls used 
for a study of breast cancer (matched to cases by age and 
year of blood dmw) and 350 used for a study of pancreatic 
cancer (matched to cases by age, sex, mce and date of 
blood draw). Of these controls, 59 were included in more 
than one study; thus, in total, 2621 control subjects from the 
Prostate Lung Colon and Ovarian Trial were included in this 
present data analysis. As there were only 157 non-Caucasians 
in these data, we only present results fo r these Caucasian sub­
jects (25(0H)D, n 2465; 1,25(0H)2D, n 1369). At the initial 
screening, all participants were asked to complete a question­
naire on medical history, including diabetes, hypertension and 
CHD as well as demography, anthropometry, li festyle factors 
(including smo king history, menopausal hormone thempy 
use and vigorous physical activity (PA) during the previous 
year) and usual dieta1y intake over the 12 months before 
enro lment (137-item FFQ and fourteen questions about 
intake of vitamin and mine1-al supplements)00) Because of 
the self-reported nature of the questionnaire, the medical diag­
nosis questions were repeated on the same population 5 years 
later with 87o/o repeatability for diabetes, 89o/o for hype•ten­
sion and only 55 o/o for CHD. Daily nutrient in take from 
foods was calculated by multiplying the reported frequency 
of consumption of each food item by the nuu·ient composition 
of the imputed sex-specific portion size, using th e nutrient 
database from the US Department of Agriculture0 1) Ca and 
vitamin D intakes were measured both from food and sup­
plemental sources. Serum samples were collected during the 
baseline visit and stored at -70°C. Levels of serum 25(0H)D 
and 1,25(0H)2D for subjects were determined at baseline 
using a 1-adio-iodinated tracer assay in the laborato ries of 
Hollis(12 13Horst and • ) Replicate blinded quality-control 
samples from two to four d ifferent individuals were included 
in all 25(0H)D and 1,25(0H)2D batches. The overall CV for 
25(0H)D were 16·3o/o for the colorectal adenoma, 11·4 o/o 
for non-Hodgkin 's lymphoma, 5·9 o/o for prostate, 8·2 o/o for 
the breast study and 4·7 o/o for the pancreas study and for 
1,25(0H)2D were 16·3 and 12·8o/o for adenoma and breast 
sn1dies, respectively. 
Dummy variables coded to represent each of the centres in 
the sn•dy and each of the control series (from the five case­
control studies) were included as covariates in all models as 
well as age, smoking, educational status, BMI, total dieta1y 
energy and PA, as they are known risk factors for diabetes, 
hypertension and CHD in previous sn•dies. All these variables 
were included as a priori confounders/ covariates in all multi­
variable regression models. Uncond itional logistic regression 
analyses were conducted with diabetes, hypeJtension and 
CHD as health outcomes, with 25(0H)D nmol/1 (categolised 
as >80, 50-80, 37-50 and <37) as either the independent 
variable for vitamin D stan•s or 1,25(0H)2D pmol/1(in qua1tiles: 
:::::: 103, ::::::86-103, :::::: 72- 86 and < 72). Vitamin D and Ca 
intakes (diet plus supplements) were also calculated as 
potential independent variables and also included in all models. 
Linear trends of ordered categolical valiables (e.g. cate­
golies of 25(0H)D, 1,25(0H)2D, BMI and vitamin D and 
Ca intake) were assessed using continuous va lues for each 
variable and applying a likelihood 1-atio test0 4) All statistical 
analyses were pe1formed using the SPSS 15 statistical package 
(SPSS, Inc., Chicago, IL, USA). All P values are two-sided. 
Results 
The charactelistics of the study paltlopants are repo1ted 
in Table 1. Serum 25(0H)D levels varied seasonally, with 
the highest levels during the summer and autumn months 
and the lowest levels during winter and spring (unlike 
1,25(0 H)2D levels). Unadjusted 25(0H)D and 1 ,25(0H)2D 
values were significantly lower for diabetics (Fig. 1(a) and 
(b)), those with hypertension and those with CHD (data not 
shown). Apalt from sunshine exposure, other independent 
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Circulating vitamin 0 
predicto rs of 25(0H)D levels in these data have been 
previously repo rted to be high dietary and supplement 
intake o f vitamin 0 and Ca and menopausal ho rmone therapy 
use in women, as we ll as having a high BMI and low PA 
levels(9) As 1 ,25(0H)20 levels are under tight metabo lic con­
tro l, 25(0 H)D and 1,25(0H) 2D levels were only minimally 
con·elated (r 2 0·158, P<0·001) and, also, do not va1y by 
season. In contrast to 25(0 H)D, there were no other life­
style predictors fo r 1,25(0 H)2 D except menopausal hormone 
the rapy use. Diabetes was significantly associated with lower 
levels of 25(0H)D and 1,25 (OH)2D in blood: after adjustment 
fo r confounding factors, including sex, geographical location, 
educational leve l, smoking histo1y, BMI, PA, tota l diet~uy 
energy, vitamin D and Ca intake and blood vitamin D 
(25(0 H)D o r 1,25(0H)2D (as appropliate)). Caucasians who 
had 25(0 H)D ;::: s o nmo l/1 25(0H)D were ha lf as likely to 
metabolites and diabetes 
have d iabetes (OR 0·5 (95 o/o CI 0·3, 0·9)) compared with 
those who had 25(0H)D < 37 nmol/1 (trend test: P=0·05) . 
Those in the h ighest quartile of 1,25(0H)2D (;::: 103 pmol/1) 
were a third as likely to have diabetes (OR 0·3 (95 o/o CI 0·1 , 
0·7)) than those in the lowest quaitile (<72 pmol/1; trend 
test: P=0·02) . In contrast, there we re no significant associ­
ations between 25(0H)D or 1,25 (OH)2D and CHD or hyper­
tension risk once adjustment was made fo r confounding (BMI 
was the majo r confounder) (Table 2). There were no sex 
differences with any of these chronic conditions and 
25(0H)D o r 1,25(0H)zD ( ?interaction > 0·05) . 
Discussion 
The present findings for 25(0H)D and diabetes suppott 
the results of earlier clinical and animal stud iescs-?), and are 
Table 1. Distribution of demographic, lifestyle habits and dietary intake by low serum 25-hydroxyvitamin D (25(0H)D) and 1 ,25-dihydroxyvitamin D 
(1 ,25(0H)2D), diabetes, hypertension and CHD status in Caucasian healthy middle-aged men and women living across the USA 
25(0H)D 1,25(0H)2D 
Total < 37nmol/l < 72pmoVI Diabetes Hypertension CHD 
(n 2465) (n269) (n 352) (n 170) (n724) (n248) 
Categorical variablest (%) 
Demographics 
Sex: female 47 46 71 33** 55 23** 
Education: above high school 93 92 94 88** 91* 94 
Chronic conditions and lifestyle habits 
Diabetes 7 11* 9* 12** 16** 
CHD 10 12 10 24** 19** 
Hypertension 30 36* 33 50** 54** 
Lifestyle habits 
MHT use (current):j: 54 45* 41** 43 52 45 
MHT use (ever)§ 71 63 66 57* 69 59* 
Smoking (pack years) > 40 25 25 22 37** 29* 31* 
Vigorous exercise (current) (;;,: 3 hfweek) 40 28** 36 35 36** 43 
Vitamin supplement intake 
Multi-vitamins (recent) 65 48** 70 53** 62 63 
Continuous v ariablesll 
Age (years) 
Mean 63 63 63 65** 64** 66** 
SD 5 5 4 5 5 5 
Anthropometry 
BMI (current; kg/m2 ) 
Mean 27 29** 28 30** 29** 28** 
SD 5 5 6 6 5 5 
Nutrients from diet and supplements 
Energy from diet (kJ/d) 
Mean 8680 8575 8115 8826 8717 9044 
SD 3587 3557 3189 4436 3821 3553 
Total fat from diet (g/d) 
Mean 69 67 64 74* 69 70 
SD 35 32 31 40 36 35 
Ca from diet and supplements (mgld) 
Mean 1261 1022** 1353 1237 1197** 1182* 
SD 631 530 681 823 609 550 
Vitamin E from diet and supplements (mg/d) 
Mean 182 123** 210 159 183 209 
SD 254 222 272 240 262 271 
Vitamin D from diet and supplements (~tg/d) 
Mean 12 7** 12 11 11* 11 
SD 9 7 8 9 8 8 
MHT, menopausal hormone therapy. 
Values were significantly different: *P< 0·01, *"P< 0-001. 
t x 2 P value testing for d~ference between the category v. the converse. 
+n 616 women. 
§n813 women. 
II P value for significance of Pearson correlation coefficient. 
K. E. Brock eta/.342 
consistent with other large epidemiological cross-sectional 
studies that have investigated the relationship between 
serum 25(0H)D levels and diabetes<s,IS) Two recent prospec­
tive investigations also supp01t this hypothesis: in the first 
study, which was conducted among 524 women and men in 
the UK, baseline 25(0H)D levels were inversely associated 
with glycaemia and insulin resistance after a 10-year follow­
up06) In the second study, which used data from two 
nested case-contro l studies in Finland, baseline 25(0H)D 
levels were significantly inversely associated with type 2 
diabetes 1isk after a 22-year follow-up, but only in men° 7) 
None o f these studies investigated associations with 
1,25(0H)2 D nor did they investigate CHD or the risk of 
hype1te nsion. 
Several small clinical inte ivention studies also support that 
vitamin D, o r its active metabo lite 1,25(0H)2 D, improves insu­
lin sensitivity, even in subjects with g lucose metabolism par­
ameters classified within no rmal ranges<s) The mechanisms 
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proposed to explain th is effect include potential relationships 
with improvements in lean mass, regulation of insulin release, 
altered insulin recepto r expression and specific effects on 
insulin action. These actions may be med iated by systemic 
or local p roduction of 1,25(0H)2D or by suppression of the 
parathyroid hormone, which may function to negatively 
affect insulin sensitivity0 - 7·15- 19) However, since the present 
study is cross-sectional, we cannot rule out that being diabetic 
could modify the regu lation of renal synthesis o f 1,25(0H)2 D, 
which would be reflected in the concentration of this 
hormone in the blood. 
Vitamin D status is of interest with respect to diabetes 
because of its potentia l as a target for inte1vention. Maintain­
ing adequate vitamin D status has proven to be challenging, 
as sunlight is the only substantial natural source of vitamin 
D fo r humans; given the low intensity of UV light in the 
winter and many people's indoor lifestyles, vitamin D 
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Fig. 1. (a) Distribution of 25-hydroxyvitamin D (25(0H)D) (nmoln) levels by month of blood draw for diabetic ( • 1 ·) and non-diabetic ( -+-) healthy middle­
aged Caucasian US men and women. (b) Distribution of 1,25(0H),D(pmoln) levels by month of blood draw for diabetic (·I ·) and non-diabetic ( -+-) healthy middle­
aged Caucasian US men and women. 
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Circulating vitamin 0 metabolites and diabetes 
Table 2. Association between dietary vitamin D and calcium intake and serum 25-hydroxyvitamin D (25(0H)D) (nmol/1) and 1 ,25-dihydroxyvitamin D 
(1 ,25(0HbD) (pmol/1) and diabetes, hypertension and CHD prevalence in Caucasian men and women living across the USA 
Diabetes (n 170) Hypertension (n 724) CHD (n 248) 
Serum/diet n2465 OR* 95 % CI ORt 95 % CI OR* 95 % CI ORt 95 % CI OR* 95 % CI ORt 95% CI 
25 (OH)D:j: (nmol/1) 
< 37 269 1·0 1·0 1·0 1·0 1·0 1·0 
;;,: 37-50 442 0·7 0-4, 1·2 0·7 0-4, 1·2 0·8 0·6, 1·1 0 ·9 0 ·6, 1·2 0·7 0-4, 1·2 0·7 0-4, 1·1 
;;,: 50-80 1239 0·7 0-4, 1·0 0·7 0-4, 1·1 0·7 0·6, 1·0 0 ·9 0 ·7, 1·2 1·0 0·6, 1·4 1·1 0·7, 1·7 
;;,: 80 514 0·3 0·2, 0·6 0·5 0·3, 0·9 0·6 0·5, 0·9 1·0 0 ·7, 1-4 0·5 0·3, 0 ·9 0·7 0-4, 1·3 
Ptrend < 0·001 0·02 0·004 NS NS NS 
Ca from diet and supplements (mg/d) (quartiles) 
< 791 595 1·0 1·0 1·0 1·0 1·0 1·0 
;;,: 791 to < 1137 618 0·8 0·5, 1·2 0·9 0·6, 1·5 0·8 0·7, 1·1 0 ·8 0 ·6, 1·1 0·8 0·6, 1·2 0·7 0·5, 1·1 
;;,: 1137 to < 1597 621 0·7 0-4, 1·0 0·8 0-4, 1·3 0·8 0·7, 1·1 0 ·8 0 ·6, 1·1 0·9 0·6, 1·3 0·9 0·5, 1·3 
;;,: 1597 631 0·7 0·5, 1·1 0·8 0-4, 1·5 0·7 0·5, 0·9 0 ·7 0·5, 1·0 0·7 0·5, 1·0 0·7 0-4, 1·1 
Ptrend NS NS 0·004 0 ·05 0·06 NS 
Vitamin D from diet and supplements (~g/d) (quartiles) 
< 4·5 599 1·0 1·0 1·0 1·0 1·0 1·0 
;;,: 4·5 to < 11 624 1·2 0·8, 1·9 1·2 0·7, 1·8 0·9 0·7, 1·1 1·0 0 ·7, 1·3 1·3 0·9, 1·8 1·2 0·8, 1·8 
;;,: 11 to < 16 629 0·9 0·6, 1·5 0·9 0·5, 1·5 0·9 0·7, 1·1 1·1 0 ·8, 1-4 1·1 0·8, 1·6 1·5 1·0, 2·3 
;;,: 16 613 0·8 0·5, 1·2 0·8 0·4, 1·4 0·8 0·6, 1·1 1·1 0 ·8, 1·5 0·9 0·6, 1·4 1·2 0·7, 2·0 
Ptrend NS NS NS NS NS NS 
Diabetes (n 80) Hypertension (n 405) CHD (n 105) 
1,25(0H)2D (pmol/1) n 1369 OR* 95 % CI OR§ 95 % CI OR* 
< 72 352 1·0 1·0 1·0 
;;,: 72- 86 347 0·7 0-4, 1·2 0·8 0-4, 1·5 1·0 
;;,: 86-103 339 0·6 0·3, 1·1 0·8 0-4, 1·5 0·9 
;;,: 103 331 0·2 0·1, 0·5 0·3 0·1, 0·7 0·7 
Ptrend < 0·001 0·02 
95 % CI OR§ 95 % CI OR* 95 % CI OR§ 95% CI 
1·0 1·0 1·0 
0·7, 1-4 1·1 0 ·8, 1·5 0·6 0·3, 1·0 0·5 0·3, 1·0 
0·6, 1·2 1·0 0·7, 1-4 0·7 0·4, 1·2 0·9 0·5, 1·5 
0·5, 1·0 0 ·8 0 ·6, 1·2 0·7 0·4, 1·2 0·9 0·5, 1·7 
0·03 NS NS NS 
• Unadjusted for confounders and covariates. 

t Adjusted for 1,25(0H)2D, study centre, different case-control study vitamin D analysis, date of blood draw, pack years of smoking, educational level, BMI, physical activity, 

sex, total dietary energy, dietary vitamin D and Ca plus supplements where appropriate. 
:!:Missing data 25(0H)D (n 1). 
§Adjusted for 25(0H)D level, study centre, different case-control study vitamin D analysis, date of blood draw, pack years of smoking, educational level, BMI, physical activity, 
sex, total dietary energy, dietary vitamin D and Ca plus supplements where appropriate. 
suppl ied through sun exposure is often inadequate to avoid 
deficiency. 
In contrast to our findings, othe rs, but not all, have reponed 
associations between low levels of vitamin 0 in the blood and 
hype1tensio n<4); in summa1y, eighteen out of twenty-six cross­
sectional studies (n 22- 12644) and of the two prospective 
studies, only one was positive<z,s) As increased BMT is re lated 
to both hyp ertension and low vitamin D levels, it is important 
to consider it as a confounder in these studies. Only half of the 
positive observational studies adjusted fo r BMT; it should be 
noted that in the present data, a significant association with 
25(0H)D or 1,25(0H) 2D concentrations d isappeared once 
BMI was added to the mode l. Similarly, the results from 
small , randomised, control ttials have been variable with less 
than half positive<s) Three of the large observational studies 
in the USA, UK and Germany reponed significant associations 
between 25(0H)D and risk of hypenension afte r adjustment 
fo r d iabetes prevalence<2•15·18) One postulated mechanism 
fo r vitamin D-mediated reduction of hypertension involves 
reno-protective effects, i.e . increased activation of the re nin­
angiotensin- aldosterone system, which is the main regulato r 
of electro lyte and volume homeostasis that contributes to 
4the develo pment of a1t e rial hype1tension<3• ) 
In contrast to our fi nd ings, some p revious epidemiological 
studies have found a negative association between serum 
vitamin D and heart disease<3), with ten o ut of twelve 
observational studies (n 238-4839) of vascular disease 
(includ ing two peripheral ane1y disease, five CVD) and five 
myocardia l infarction) and six out of seven observational 
studies of heart fa ilure (n 25- 3299) showing a negative associ­
ation between lower 25(0H)D levels and disease. Of these 
studies, only seven out of twelve adjusted for hype1tension 
and diabetes, but none of these repo1ted all three conditions 
2separately in the same stud/ •3) It is thought that vita min D 
plays a role in maintaining card iovascular homeostasis both 
through direct action of 1,25(0H) 2D on cardiomyocytes and 
indirect actions on circulating parathyroid honnone and Ca 
levels. The lack of association with CHD seen in these data 
could have been because of the low repeatabi lity of the self­
reponed nature of this outcome variable and its associated 
va riability compared with that of hypertension o r diabetes. 
The strengths of the present investigation are its large 
sample size, relatively low deficiency levels and the fact that 
the vitamin D analyses were all perfo rmed by the same 
assay method. Moreover, the present analysis is unique in 
repon ing, in a large cohott study, the association between 
diabetes and blood levels of 1,25(0H)2D; to our knowledge, 
only associations of 1,25(0H)2D with hypertension<4), 
CHo<3) and BMI<zo) have been repo1ted in large e pidemio­
logical groups. Tmpottant limitations of the present study 
include its cross-sectional design and reliance upon self­
repott of d iabetes, hypettension and CHD status; however, 
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K. E. Brock eta/.344 
the measures of hyp ertension and diabetes had high reliabi lity 
on follow-up. We had only one measure of adiposi ty (BMI), 
not total body fat, w hich is often thought to be more accurate; 
how ever, a recent validation study of BMI and dual -emission 
X-ray absorptiometry has repotted ve1y favourable con·e­
lations with adiposity(ZJ) We used only education as a 
marker for social class; however, this has been well accepted 
as the best marker for social class on an epidemio logical 
22 24levet< - ) In pa1ticu lar, we cannot rule out the possibi lity 
that changes in sun exposure and/ o r diet as a consequence 
of having diabetes may have led to our findings; however, 
the associations reponed here war rant investigation in large 
p rospective studies. In summa1y, these data outlining the 
positive association between vitamin D b lood markers and 
diabetes i ndicated the need for more investigation both at 
the biochemical and epidemiological levels. 
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